CFO appointment

Sensei Biotherapeutics, Inc. appoints Brian Stephenson as CFO

Sensei Biotherapeutics, Inc. reported in a Form 8-K filed June 15, 2026 that Brian Stephenson was appointed Chief Financial Officer, effective June 13, 2026.

In the filing's words

Effective as of June 13, 2026, Brian Stephenson was appointed as the Company’s Chief Financial Officer and principal financial officer.

Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.

Company	Sensei Biotherapeutics, Inc. (SNSE)
Event	Appointment
Incoming	Brian Stephenson
Title in the filing	Chief Financial Officer
Effective	June 13, 2026
8-K filed	June 15, 2026
Internal promotion	Not established by the source
SEC CIK	0001829802

Sensei Biotherapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 15, 2026. The filing's own words are quoted above.

Same industry, June 2026

Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.

4 months ago· 2026-06-30InterimIMNN

Imunon, Inc. names Josh Blacher interim CFO

4 months ago· 2026-06-30TransitionRANI

Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford

4 months ago· 2026-06-29InterimCVKD

Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO

5 months ago· 2026-06-18InterimMPLT

MapLight Therapeutics, Inc. names Jonathan Gillis interim CFO

5 months ago· 2026-06-18TransitionPTPI

Petros Pharmaceuticals, Inc. CFO transition: Robert Weinstein to succeed Mitchell Arnold

5 months ago· 2026-06-12AppointmentOCUL

Ocular Therapeutix, Inc. appoints Jason Robins as CFO

5 months ago· 2026-06-04AppointmentBYSI

BeyondSpring Inc. appoints Na Li as CFO

5 months ago· 2026-06-03InterimCVKD

Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO

Sources

sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26

Something wrong about Brian Stephenson? Send a correction with the primary source.